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GENERAL BACKGROUND 
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1.1. INTRODUCTION 
 
Mortality by CVDs (cardiovascular diseases) accounts for 31% of all deaths worldwide (World 
Health Organization, 2015). The most common form of heart disease is CAD (coronary artery 
disease) where functional CMs (cardiomyocytes) die out in the heart and are replaced by fibrotic scar. 
This eventually causes decreased heart function and heart failure leading to heart attacks or stroke. 
Since adult CMs possess very limited self-regenerative capability, heart transplantation has been the 
most effective way of therapy for heart patients. However, limited access to donor organs and 
existence of potential problems with immunosuppression and graft vascularization, heart 
transplantation is a limited option for most patients with end-stage heart diseases. Rather, cellular 
therapies offer a more accessible option for a broader group of coronary heart patients. Currently, 
there are four major cellular therapy approaches: 1) transplantation of autologous adult stem cells, 2) 
transplantation of ESC- or iPSC-derived CMs, 3) forced proliferation of adult CMs, and 4) cell fate 
reprogramming. Transplantation of autologous adult stem cells, such as progenitor cells and bone 
marrow-derived MSCs, provides very limited regeneration, as they are not differentiating into CMs 
but rather providing some cardioprotection through paracrine signaling. Another approach is the 
transplantation of differentiated CMs from pluripotent stem cells. They also possess limited benefit to 
heart function since in vitro differentiated CMs are immature, show limited coupling with the resident 
CMs, and possess limited viability. Third approach is the forced cell-cycle reentry of adult CMs. Cell 
cycle reentry in CMs carry potential concerns regarding efficacy and safety. It is still unknown if 
proposed methods can provide sufficient number of CMs for a potential clinical therapy. On the other 
side, non-specific cell cycle activation in the resident non-myocyte cells might induce tumorigenesis. 
Forth approach is the direct cardiac reprogramming of resident non-myocytes in the scar into 
functional iCMs (induced cardiomyocytes). In this chapter, I will review the discovery and progress 
of direct cardiac reprogramming. 
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1.2. HISTORY AND PROGRESS OF DIRECT CARDIAC REPROGRAMMING 
 
1.2.1. Development of Direct Cardiac Reprogramming by Cardiac Transcription Factors 
 
A single transcription factor, MyoD, has been identified as the master regulator of skeletal muscle 
cells, yet it has not been known if any master regulator exists for other cell lineages until the 
discovery of induced pluripotent stem cells (iPSCs) in 2006 [1] A single transcription factor was not 
enough to induce iPSCs from fibroblasts, however, a combination of Oct4, Sox2, Klf4, and c-Myc 
were able to convert a terminally differentiated cell type into pluripotent cells [2]. Discovery of iPSCs 
opened a new avenue for direct reprogramming of adult cell types into different cell lineages [3]. In 
2010, Ieda et al [4] discovered a minimal combination of transcription factors (GMT: Gata4, Mef2c, 
and Tbx5), which convert cardiac fibroblasts into induced cardiomyocytes (iCMs). They utilized a 
cardiac reporter gene expressing GFP under the promoter of aMHC (aMHC-GFP), which was 
expressed in reprogrammed cells [4]. aMHC-GFP+ iCMs expressed a group of cardiac genes, e.g. 
Mhy6, Actc1, Actn2, etc., and showed sarcomere assembly. 2 weeks after reprogramming induction, 
some iCMs showed spontaneous calcium oscillations and 0.01-0.1% of transduced cells were able to 
spontaneously beat. Besides, iCMs had action potentials similar to ventricular cardiomyocytes. 
Moreover, iCMs did not express progenitor markers, cKit, Isl1 and Mesp1 during reprogramming 
initiation, suggesting that GMT directly reprogrammed iCMs without an intermediate stem/progenitor 
cell stage. 
 
Transcription factor-based approach has been used for discovering new methods to improve 
reprogramming efficiency and quality. Song et al added Hand2 to GMT cocktail (GHMT) and 
improved in vivo reprogramming efficiency [5]. They had 3-fold more aMHC-GFP/cTnT double-
positive iCMs in adult murine tail-tip fibroblasts (TTFs) and 5-fold more in adult cardiac fibroblasts 
than with GMT. They also showed GHMT could induce beating iCMs, suggesting Hand2 is a 
reprogramming enhancer. Protze et al [6] screened a library of transcription factors and found that an 
optimal combination of Mef2c, Tbx5, and Myocd could generate iCMs positive for multiple cardiac 
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genes. Addis et al [7] used a different reporter system in which the calcium indicator GCaMP is 
coexpressed with human cTnT. They added Nkx2.5 to GHMT reprogramming factors and showed 50-
fold more iCMs with spontaneous calcium oscillations, cardiomyocyte markers, and spontaneous 
beating. Hirai et al [8] fused MyoD domain to Gata4, Hand2, Mef2c, and Tbx5 and transduced fusion 
genes into non-cardiac fibroblasts. MyoD-Mef2c fusion with other three wild-type genes yielded 15-
fold more beating iCMs than transduction with combination of all 4 wild-type genes.  
 
1.2.2. Generating iCMs without Cardiac Transcription Factors 
 
By a different approach from transcription factor-based system, Jayawardena et al [9] tested a 
combination of microRNAs (miRs) for their iCM induction ability. A combination of muscle-specific 
miRs (miR1, miR133, miR208, and miR409) could induce iCMs from mouse CFs. JAK inhibitor 
improved reprogramming capability of miR combo [9]. Their study did not demonstrate mechanism 
of reprogramming by miRs and functional aspects of iCMs generated with miRs have not been well 
studied. Muraoka et al [10] showed that miR133 improved number of beating iCMs 7-fold in MEFs 
compare to GMT alone and shortened time of beating iCMs after gene transduction through 
suppression of Snai1, a master regulator of epithelial-to-mesenchymal transition.  
 
Alternatively, Wang et al [11] reported that cardiac reprogramming could be achieved without cardiac 
transcription factors. They used four compounds (SB431542, CHIR99021, Parnate, and Forskolin) 
together with Oct4 transduction. Mouse fibroblasts were converted into iCMs by passing through a 
cardiac precursor state and mostly converted into ventricular cardiomyocyte-like cells. Moreover, Fu 
et al [12] succeeded to reprogram chemical-induced cardiomyocyte-like cells (CiCMs) from mouse 
fibroblasts by only a chemical compound cocktail consisted of CHIR99021, RepSox, Forskolin, VPA, 
Parnate, TTNPB, and DZnep (CRFVPTZ). CiCMs passed through a cardiac progenitor stage by 
upregulating Sca-1, Wt1, Flk1, Abcg2, and Mesp1 in the early stages of reprogramming, yet also 
expressed pluripotency markers, Oct4, Nanog, Sox2, Rex1, at low levels. However, CiCMs generated 
from fibroblasts of Oct4-GFP mice did not induce Oct4-GFP+ cells, suggesting that CiCMs pass 
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through a cardiac progenitor state, but not a pluripotent stage. Similarly, Cao et al [13] showed that 
human fibroblasts could also be converted into beating iCMs with a combination of chemical 
compounds, composed of CHIR99021, A83-01, BIX01294, AS8351, SC1, Y27632, OAC2, SU16F, 
and JNJ10198409. They also showed that cells were initially passed through a progenitor stage and 
finally converted into functional iCMs, suggesting that chemical compound-based reprogramming has 
a different mechanism of reprogramming from cardiac reprogramming with GMT transcription 
factors. 
 
1.2.3. Attempts to Reveal Mechanism of Cardiac Reprogramming  
 
Activation or inhibition of signaling pathways has been shown to alter efficiency of iCM 
reprogramming. Ifkovits et al [14] demonstrated that inhibition of transforming growth factor beta 
(TGF-b) enhanced reprogramming of iCMs in MEFs and CFs. Zhao et al [15] showed that inhibition 
of Rho-associated kinase (ROCK) pathway increased conversion rate of iCMs in MEFs, TTFs, and 
CFs. Conversely, activation of TGF-b or ROCK in iCMs attenuated cardiac reprogramming, 
suggesting that profibrotic signaling is a barrier to reprogramming induction. Our study showed that 
~16% of iCMs in early stages of reprogramming was apoptosized (Unpublished data), that’s why; 
ROCK inhibitors might improve reprogramming by suppressing apoptosis in reprogrammed iCMs. 
Zhou et al [16] demonstrated that overexpression of Akt1 together with GHMT transcription factors 
reprogrammed 50% of MEFs into iCMs with spontaneous beating as early as day 20. Akt1 improved 
maturation of iCMs through activation of Akt1 downstream targets, mTORC1 and Foxo3a. On the 
other hand, Yamakawa et al [17] defined a serum-free condition with combination of FGF2, FGF10, 
and VEGF (FFV), which improved induction of beating iCMs compare to serum-based culture. FFV 
enhanced reprogramming through activation of endogenous Gata4 and activation of MAP kinase and 
PI3K/Akt pathways. Additionally, Wnt signaling inhibition by IWP4 further improved induction of 
beating iCMs with FFV. 
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We also had an effort to enlighten a part of the mechanism of reprogramming in murine cells. We 
facilitated cell cycle exit through transient arrest of cell cycle at S or G2/M phase after transduction of 
GMT single factors. Our data showed that iCMs arrested at S or G2/M diminished proliferation and 
inhibited cell cycle genes, yet improved cardiac gene expression. Our finding suggested that cell cycle 
exit is a required process for faster maturation of iCMs (Unpublished data). Similarly, a single 
polycistronic MGT construct, generated by Wang et al [18], facilitated cell cycle exit and improved 
maturity of iCMs in our hands (Unpublished data).  MGT offers an optimal stoichiometry of 
transcription factors compared to mixture of single factors with heterogeneous expression. We 
demonstrated that MGT stoichiometry offers a better reprogramming by inducing cell cycle exit in an 
earlier stage than single GMT factors could do. 
 
Reprogramming of iCMs requires overcoming epigenetic barriers that were established in fibroblasts. 
Modulation of epigenetic states in the cells improves reprogramming success. Liu et al [19] analyzed 
histone and DNA methylations in iCMs generated by a polycistronic MGT. MGT increased 
expression of trimethylated histone H3 of lysine 4 (H3K4me3), which marks active chromatin, and 
diminished trimethylated histone H3 of lysine 27 (H3K27me3), which marks inactive chromatin, in 
cardiac gene promoters as early as day3 of MGT transduction. On the contrary, MGT decreased 
H3K4me3 and increased H3K27me3 in fibroblast genes. Moreover, DNA methylations on CpG 
islands on the promoters of cardiac genes Mhy6 and Nppa were decreased within 3 days of MGT 
transduction, suggesting DNA methylation on cardiac gene promoters as a barrier for cardiac 
reprogramming. The study by Zhou et al [20] similarly demonstrated that Bmi1 suppression improved 
induction of iCMs through decreased methylation on cardiac genes.  
 
1.2.4. Direct Reprogramming of Human Fibroblasts 
 
To be able to translate cardiac reprogramming to clinical therapies, it is essential to optimize 
reprogramming cocktails for human cells and understand the mechanism of reprogramming. Research 
teams including ours investigated cardiac reprogramming in human fibroblasts. Nam et al [21] 
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showed that combination of GHMT (Gata4, Hand2, Mef2c, and Tbx5) was no sufficient to reprogram 
human fibroblasts. They screened additional transcription factors and revealed that adding Myocd to 
GHMT significantly increased cTnT+ iCMs from neonatal and adult human fibroblasts. Moreover, 
addition of miR1 and miR133 further enhanced reprogramming and eliminated the requirement for 
Mef2c. 8 weeks after transduction of 6 factors into adult human cardiac fibroblasts (CFs), iCMs 
showed spontaneous calcium oscillations and a small portion of iCMs spontaneously contracted 11 
weeks after transduction of 6 factors.  
 
Wada et al [22] reported that GMT was not sufficient for human cardiac reprogramming and addition 
of Myocd and Mesp1 to GMT (GMTMM) was sufficient to convert human cardiac and dermal 
fibroblasts into iCMs. They showed that around 5% of iCMs from CFs with GMTMM expressed 
cTnT and a-actinin. Moreover, iCMs showed increased cardiac and decreased fibroblast gene 
expression. aSMA staining in iCMs revealed that a-actinin-positive iCMs were positive for aSMA, a 
marker of embryonic cardiomyocytes, meaning that iCMs are mostly immature type cardiomyocytes. 
 
We reported that addition of Esrrg and Mesp1 to GMT (5F) reprogrammed human fibroblasts into 
iCMs [23]. We utilized a transgenic H9 human ESC line carrying mCherry under the promoter of 
aMHC gene. We then differentiated aMHC-mCherry hESCs into fibroblasts and used as a cell source 
for reprogramming. We selected 13 transcription factors and 3 growth factors and transduced them all 
into fibroblasts along with GMT factors. GMT + 16 factors induced aMHC-mCherry+ iCMs. By 
eliminating inhibitory and unnecessary factors, we found that a minimal combination of Esrrg, Mesp1 
and GMT was sufficient to induce aMHC and cTnT double-positive iCMs. Moreover, addition of two 
more factors, Myocd and ZFPM2, to 5F combination (7F) further increased iCM yield. iCMs with 
either 5F or 7F showed calcium transients and resting membrane potential similar to that of adult CMs 
and global gene expression shifted from fibroblasts to cardiomyocyte-like state, however, did not 
spontaneously contracted. More recently, Mohamed et al [24] added TGF-b and Wnt signaling 
inhibitors to 7F combination and induced 50% of 7F-transduced human CFs into iCMs with 
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spontaneous calcium oscillations while 7F by itself showed less than 5% of cells with calcium 
oscillations. 
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1.3. CELL CYCLE IN EPIGENETIC REPROGRAMMING 
 
1.3.1. Cell Cycle in iPSC Reprogramming 
Chen et al [25] synchronized human dermal fibroblasts (HDFs) at G1 phase by serum-free media 
prior to induction of iPSCs and showed increased portion of TRA1-60+ 15-20 folds compared to 
unsynchronized HDFs. Synchronization of HDFs increased retroviral infection efficiency and 
increased mesenchymal to epithelial transition (MET), which is one essential event during epigenetic 
reprogramming of cells. Moreover, iPSCs generated with synchronization had no loss in pluripotency 
marker expression and differentiation ability in vitro. 
 
1.3.2. Cell Cycle in Induced-neuron Reprogramming 
Jiang et al [26] synchronized human fetal lung fibroblast MRC5 (Medical Research Council 5) at G1 
phase by various methods of synchronization, including serum-free media, and significantly improved 
reprogramming of TH+ or Tuj1+ induced dopaminergic (iDA) neurons in vitro. On the other hand, 
their study showed that iDA neurons rapidly exit cell cycle upon reprogramming induction, within 24 
hours of reprogramming induction, and majority of EdU+ proliferating cells failed to be 
reprogrammed, suggesting that cell cycle exit is an essential process for reprogramming of iDA 
neurons. 
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2.1. ABSTRACT 
 
Rationale: Direct reprogramming of fibroblasts into induced cardiomyocytes (iCMs) holds a great 
promise for cardiac regenerative medicine. However, low conversion rate and immaturity remain as 
the main hurdles. Generating more mature and quality iCMs underlies a better mechanistic 
understanding of the reprogramming process. Cell cycle regulation, a general mechanism of the cells, 
has not been well understood in iCMs.  
 
Objective: We proposed to research how proliferation and cell cycle exit are involved in iCM 
reprogramming.  
 
Methods and Results: We utilized αMHC-GFP transgene to follow up live progress of 
reprogramming. Serial pictures of immature αMHC-GFP+ iCMs at DPI-2-4 (post-infection days)	
revealed that approximately half of the cells proliferated after turning on αMHC-GFP reporter and 
this rate decreased gradually until they all finally exit cell cycle at DPI-21. Moreover, transient cell 
cycle arrest at S and G2/M phases in immature iCMs facilitated cell cycle exit and diminished cell 
cycle marker gene expression. Early onset of cell cycle exit through cell cycle synchronizing drugs 
decreased the yield of αMHC-GFP+ iCMs, yet improved expression levels of essential cardiac genes. 
On the other hand, a single polycistronic construct of reprogramming factors (MGT) with P2A and 
T2A sequences limited proliferation capability of αMHC-GFP+ iCMs and facilitated cell cycle exit in 
earlier stages. MGT, similarly, decreased cell cycle gene expression, yet improved cardiac gene 
expression in αMHC-GFP+ iCMs. Interestingly, we found that GFPhigh population of iCMs exhibited 
improved cardiac gene expression and decreased cell cycle and proliferation gene expression compare 
to GFPlow iCMs. MGT reprogrammed a bigger portion of MEFs into GFPhigh iCMs. This assured that 
GFPhigh cell population is a more desired form of iCMs. 
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Conclusions: Our results indicate that proliferation is undesired for iCM maturation, and cell cycle 
exit at earlier stages of reprogramming is beneficial for maturation of iCMs. A better understanding of 
cell cycle exit in iCMs will help generating more mature and functional iCMs.   
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2.2. BRIEF BACKGROUND 
 
Cardiomyocytes (CMs) in the adult heart have limited regenerative capacity (Van Berlo and 
Molkentin, 2014). At the onset of heart disease, lost CMs are typically replaced with fibrotic scar 
tissue, subsequently leading to chronic heart failure, which remains one of the leading causes of death 
worldwide. Recent studies have found that mouse (Ieda et al., 2010; Jayawardena et al., 2012; Song 
et al., 2012; Qian et al., 2012) and human (Fu et al., 2013; Nam et al., 2013; Wada et al., 2013) 
fibroblasts can be directly reprogrammed into induced CMs (iCMs), which holds a great promise for 
the development of a new therapeutic approach for heart disease. In order to improve induction 
efficiency and quality of iCMs, studies have focused on developing optimized reprogramming 
methods and investigating the mechanism of direct cardiac reprogramming, including the use of 
polycistronic vectors for an optimal stoichiometry of reprogramming factors (Wang et al., 2015), 
suppression of critical epigenetic barriers (Zhou et al., 2015; Zhou et al., 2016) and pro-fibrotic 
signaling (Muraoka et al., 2014; Ifkovits et al., 2014; Zhao et al., 2015), optimization of culture 
conditions (Yamakawa et al, 2015; Mohamed et al., 2017), and suppression of inflammatory 
process (Zhou et al., 2017a). However, the cell-cycle regulation, a fundamental biological process, 
has not been investigated during iCM-reprogramming. 
 
Similar to fully differentiated adult CMs, it has been recognized that reprogrammed iCMs exit the cell 
cycle.  No cardiac troponin-T (cTnT)+ iCMs were positively stained with Ki67 at week-2 of 
reprogramming (Addis et al., 2013); 5-ethynyl-20-deoxyuridine (EdU) assay didn’t show any EdU+ 
iCMs from week-2 to week-4 post-induction (Yamakawa et al., 2015). More recently, none of the α-
Actinin+ iCMs expressed proliferation marker, Ki67, at DPI-28 (Zhou et al., 2017b). These studies 
indicate that cell cycle exit is an important event happening during the process of iCM-
reprogramming; however, it is unknown whether cell-cycle exit of reprogrammed iCMs happens right 
upon reprogramming induction or at a later stage of reprogramming process. A cell cycle constitutes a 
critically important chain of interconnected events with a dynamic fluctuation of epigenetic chromatin 
modifications (Bou Kheir and Lund, 2010), including genomic DNA methylation and histone 
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modification, which have significant influence on epigenetic reprogramming of somatic cell fate 
(Buganim et al., 2013). Indeed, it has been reported that pre-synchronization of fibroblasts at the 
G0/G1-phase by transient serum starvation could significantly improve the reprogramming yield of 
induced pluripotent stem cells (iPSCs) (Chen et al., 2012). In addition, cell-cycle pre-synchronization 
at the G1-phase could markedly enhance the reprogramming efficiency of induced dopaminergic 
neurons (Jiang et al., 2015). These studies suggested that manipulation of cell-cycle progression has 
a significant impact on epigenetic reprogramming; however, it is unknown in which cell-cycle phase 
epigenetic iCM-reprogramming is initiated in fibroblasts and if manipulating the cell cycle (i.e. 
synchronization) of post-infected fibroblasts influences the progression of reprogramming. 
 
In this study, we first performed 48-hour time-lapse recordings to monitor the early progression of 
iCM-reprogramming and found that αMHC-GFP+ iCMs went through cell division at the early stage 
of reprogramming and exited cell cycle along the process of reprogramming. iCM-reprogramming 
was majorly initiated at late-G1- or S- phase. We also synchronized cell cycle of reprogramming 
fibroblasts at various time points post GMT-retrovirus infection and found that S-phase 
synchronization at day 1 post-infection (DPI-1) facilitated cell-cycle exit of reprogrammed iCMs and 
accelerated the early progression of reprogramming.  
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2.3. METHODS 
 
2.3.1. Mouse Embryonic Fibroblast (MEF) Isolation 
 
Transgenic mouse line overexpressing GFP (green fluorescent protein) under αMHC (α-myosin heavy 
chain) gene promoter was defined by Ieda et al (2010). Embryonic fibroblasts were prepared from 
E12.5-13.5 αMHC-GFP+ embryos. GFP expressing embryos were collected under sterile conditions, 
briefly washed in 70% Ethanol, and extensively washed in 1X PBS, followed by removal of internal 
organs and head. Remaining parts of embryos were washed in PBS and chopped into small pieces (1-
2mm3) prior to enzyme digestion. Tissue pieces were digested in 2ml of 0.125% Trypsin/EDTA per 
embryo at 37oC water bath for 20min. After every 5min, tissue pieces were pipetted up and down 5-
10 times. 2-3ml of 0.25% Trypsin/EDTA was added and incubated for another 5-10min until most 
tissue was dissociated well in trypsin. Trypsin was quenched with equal amount of medium with 
10%FBS (HyClone, ThermoScientific). Cells were filtered through a 40µM cell strainer (Falcon) and 
centrifuged at 1500rpm for 3min. Pellet was dissolved in DMEM medium with 10% heat-inactivated 
FBS, cultured at 37oC, 5%CO2 until full confluence, and used freshly or preserved at -80oC freezer for 
short-term or in liquid nitrogen for long-term storage.  
 
2.3.2. Cell Culture and Reprogramming 
 
PlatE packaging cells were cultured in PlatE medium containing high glucose DMEM with 10% FBS 
and selected with 1µg/ml puromycin (Gibco) and 10µg/ml blasticidin (Gibco). 24hrs before 
transfection, 2.5x106 cells per 6 cm dish were plated in PlatE medium without selection antibiotics. 
3ug pMX retroviral plasmids of Gata4, Mef2c, and Tbx5 (GMT) plasmids (Ieda et al., 2010) or 
polycistronic Mef2c-Gata4-Tbx5 (MGT) plasmid expressing P2A and T2A cleavage peptide sites 
(Wang et al., 2015) and 9uL of FugeneHD transfection reagent (Promega) were incubated in Opti-
MEM media (Gibco) at room temperature for 20min. 24hrs after transfection, medium was refreshed 
with PlatE medium. Viruses were harvested 48hrs after transfection and filtered through 0.45uM low 
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protein-binding filters (Nalgene, ThermoScientific). MEFs were infected with 0.5ml MGT or 1.5 ml 
mixture of individual GMT viruses for 24hrs with 8ug/ml final concentration of polybrene 
(Millipore). The medium was changed into and thereafter maintained in cardiac reprogramming 
medium (DMEM/M199 (4:1) with 10% heat-inactivated FBS (Hyclone, ThermoScientific), NEAA 
(Gibco), and L-Glutamine (Gibco)). Media were changed every 2-3 days until iCMs were analyzed at 
either Day7 or Day10. For evaluation of reprogramming efficiency, the cells were harvested by 0.05% 
Trypsin/EDTA, dissolved in FACS buffer (2mM EDTA and 5%FBS in 1X PBS), and analyzed by 
BD Accuri C6 (BD Biosciences). 
 
2.3.3. Cell Cycle Synchronization 
 
iCMs were induced with monocistronic pMX GMT constructs as described and synchronized for 
24hrs using 2mmol/L Thymidine (T9250, Sigma) , 25umol/L Lovastatin (1370600, Sigma), 50ng/ml 
Nocodazole (M1404, Sigma), 2ug/ml Aphidicoline (A0781, Sigma), 2mmol/L Hydroxyurea (H8627, 
Sigma), 0.5mmol/L L-Mimosine (M0253, Sigma) or FBS-free cardiac reprogramming media. Next 
day, cells were extensively washed with 1X PBS to remove the drugs and fresh cardiac 
reprogramming media was added on cells. Cells were maintained in cardiac reprogramming media by 
refreshing media every 2-3 days until flow cytometry or qPCR analysis. 
 
2.3.4. Time Lapse Imaging of αMHC-GFP+ iCMs 
 
Cardiac reprogramming was induced as described using either GMT or MGT. Cell media was 
refreshed prior to time-lapse imaging. At DPI-2, sequential pictures of infected MEFs were recorded 
for 48hrs using DMi8 Leica fluorescent microscope (Leica Microsystems). To allow observation of 
transition from GFP- to GFP+ stage, the camera was focused on GFP- areas at DPI-2. Recorded 
pictures were analyzed by MetaMorph software (Molecular Devices) to assess proliferation of iCMs. 
Video files for images with bright field and GFP fluorescence were individually prepared in 
MetaMorph and joined together side-to-side to obtain a single video file. 
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2.3.5. EdU Assay and Cell Cycle Analysis 
 
Plain MEFs were labeled with 10mM EdU for 2hrs or iCMs for 24hrs in MEF media containing high 
glucose DMEM and heat-inactivated FBS before collecting the cells for staining. The cells were 
washed with 1X PBS, harvested in 0.05% Trypsin/EDTA, and pelleted at 1500rpm for 3min. Cells in 
pellet were fixed in 4% PFA for 15min at RT. PFA was removed by extensive washing of pellet with 
1X PBS. Cells were resuspended in 1X saponin solution and respectively stained with anti-EdU 
antibodies and nuclear staining solution (40ug Propidium Iodide (P4170, Sigma), 100ug RNaseA 
(ThermoScientific) in final volume of 500uL) by using Click-iT Plus Flow Cytometry Assay protocol 
(Life Technologies). iCMs were additionally stained with GFP-FITC antibodies (1:100) (NB100-
1771, Novus Biologicals) as recommended by Click-iT protocol. Cells were filtered through a cell 
strainer and analyzed by BD Accuri C6 (BD Biosciences). 
 
2.3.6. Western Blot Analysis 
 
iCMs were generated as described, harvested by 0.05% trypsin, washed by PBS, and lysed in lysis 
buffer (1% Triton X-100, 150mmol/L NaCl, 50mmol/L TrisHCl pH7.5, 1mmol/L EDTA). To allow 
complete lysis of cells, cells were incubated on ice for 20-30 min. Proteins were separated in SDS-
PAGE gels, transferred to nitrocellulose membranes, and stained with anti-Gata4 (1:5000, sc-1237, 
SantaCruz), anti-Mef2c (1:5000, ARP37342_T100, Aviva Systems Biology), anti-Tbx5-Flag (1:500, 
PA1-984B, ThermoScientific), and β-Actin (1:1000, A1978, Sigma) or GAPDH (1:1000, sc-166545, 
Santa Cruz) on individual blots. Pierce ECL Plus chemiluminescence detection kit (Thermo 
Scientific) was used to detect the proteins. 
 
2.3.7. Pre-amplification of Genes and qRT-PCR 
 
		 25	
iCMs were harvested by 0.05% trypsin, filtered through a cell strainer, and resuspended in FACS 
buffer. GFP+ iCMs were sorted by HAPS1 cell sorter (iCyt, Sony). Cells were lysed in 10uL 
resuspension buffer and 1uL lysis enhancer from CellsDirect One-step qRT-PCR Kit (Invitrogen). To 
complete lysis, cells were heated at 75oC for 10min in a thermal cycler. Preamplification primer mix 
was prepared by mixing all primers in a single tube at 0.5uM final concentration for each primer. 
After the lysis, the genes of interest (Table1) were pre-amplified by pre-amplification primer mix in a 
thermal cycler as recommended by CellsDirect One-step qRT-PCR kit. The pre-amplified genes were 
further amplified by SsoFast Evagreen supermix (Biorad) with individual primer sets in 7300 real-
time PCR system (Applied Biosystems). 
 
2.3.8. Statistical Analyses 
 
All data were analyzed with at least three biological replicates and expressed as mean ± SEM unless 
specified in figure legends. The statistical significance was examined by two-way paired or unpaired 
student’s t-test or ANOVA. p-value of less than 0.05 was regarded as statistically significant.   
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2.4. RESULTS 
 
2.4.1. iCMs go through cell division and exit cell cycle along with the progress of 
reprogramming 
 
For iCM reprogramming, we infected αMHC-GFP transgenic mouse embryonic fibroblasts (MEFs) 
with a cocktail of Gata4, Mef2c, and Tbx5 (GMT) retroviruses and found that GFP could be first 
observed from DPI-2, which was consistent with the observation that a high-level overexpression of 
GMT was achieved around 48 hours post-infection (Figure 1). In order to determine if cell division 
occurs during iCM-reprogramming, we recorded a 48-hour time-lapse at DPI-2 through DPI-4 to 
monitor the activation of αMHC-GFP during the early progression of iCM-reprogramming (Figure 
2A). We purposely set a three-second exposure time for GFP recording to recognize very faint GFP 
fluorescence, indicative of initial activation of αMHC-GFP (Figure 2A, frame İ); we found that the 
fluorescence of αMHC-GFP was gradually enhanced during the process of reprogramming. 
Surprisingly, we found that ~41% (39 out of 95) of αMHC-GFP+ primary GMT-reprogrammed iCMs 
(GMT-iCMs) underwent cell division once within the 48-hour recording time (Figure 2A and 2B). 
Noticeably, ~16% (22 out of 134) of GMT-iCMs died before or after cell division (Figure 2B). Our 
time-lapse recordings revealed that iCMs at the early stage of reprogramming could still actively 
divide. 
 
We next performed an EdU assay to quantify cell division of αMHC-GFP+ iCMs from DPI-4 to later 
stages of the reprogramming process. Consistent with our previous study (Ieda et al., 2010), the 
percentage of reprogrammed-αMHC-GFP+ iCMs gradually increased from DPI-4 to DPI-7, then 
decreased after two weeks (Figure 2C-2D). We then incubated retrovirus-infected MEFs with EdU 
for 24 hours to label all the dividing cells within that time; we found that more than 80% of 
uninfected MEFs divided within 24 hours (Figure 2E). Noticeably, 30.8±3.5% of GMT-iCMs at DPI-
4 were dividing and positively stained for EdU, which is consistent with our time-lapse results (DPI-2 
to DPI-4). Furthermore, the percentage of EdU+-iCMs gradually decreased from DPI-4 to DPI-21 and 
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almost none of the αMHC-GFP+ iCMs at DPI-21 were stained positively for EdU (Figure 2F), 
indicating that all iCMs, which were αMHC-GFP+/EdU-, had exited cell cycle at this late stage of 
reprogramming. Consistent with our study, none of the α-Actinin+ iCMs at DPI-28 expressed 
proliferation marker, Ki67 (Zhou et al., 2017b).  
 
2.4.2. iCM-reprogramming can be initiated in all three phases of cell cycle 
 
We next asked in which phase of the cell cycle is iCM-reprogramming initiated. To answer this 
question, we carefully calculated the time between two consecutive cell divisions of MEFs in our 
time-lapse recordings and estimated that MEFs had an average of 25.3±7.4 hours of cell-cycle length 
(n=42, Figure 3A). We performed EdU assay with two-hour EdU-labelling and measured the average 
percentages of G1 (~60%), S (~29%), and G2/M (~11%) in MEFs (Figure 3B and 3C, n=4), which 
represent the percentages of the time spent in each phase out of whole cell-cycle duration (Wieder et 
al., 1990). Therefore, the duration of G1 phase was calculated as ~15.2 hours (~60% of 25.3 hours), S 
phase ~7.3 hours, and G2/M phase ~2.8 hours (Figure 3D). We then measured the time from the 
completed cell-division back to the first appearance of the αMHC-GFP reporter (Figure 3E) and 
determined in which cell-cycle phase reprogramming of individual iCMs was initiated. For example, 
the reprogramming initiation of one iCM in Figure 2A (indicated by arrow head) was started from 15 
minutes with the first appearance of faint GFP-fluorescence (Figure 2A, frame İ) and cell division 
happened at 21 hours (Figure 2A, frame V); therefore, reprogramming of this iCM was initiated at 
G1 phase and took 20.75 hours to pass through G1 (10.65 hours), S (7.3 hours), and G2/M (2.8 hours) 
phases for a completion of cell division. These transition times from reprogramming initiation to cell 
division of GMT-iCMs (n=34, Figure 3E) were converted into a distribution chart of cell-cycle 
phases (Figure 3F). We found that 23 iCMs initiated the activation of αMHC-GFP at G1-phase, 
including 15 at late G1-phase, 10 at S-phase, and 2 at early G2-phase (Figure 3E), demonstrating that 
iCM-reprogramming were mostly initiated at late G1- and S phases. 
 
2.4.3. S- or G2/M-phase synchronization at DPI-1 facilitates cell-cycle exit of GMT-iCMs 
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Since the epigenetic status dynamically fluctuates throughout the cell cycle (Bou Kheir et al., 2010), 
we then investigated if synchronizing a specific cell-cycle phase in GMT-infected fibroblasts could 
improve iCM-reprogramming. At DPI-1, GMT-infected MEFs were synchronized at G1-, G0/G1-, 
G1/S-, or G2/M-phase, by a 24-hour incubation with lovastatin, serum-free media, thymidine, or 
nocodazole for 24 hours (Figure 4A), respectively; the morphology of synchronized MEFs displayed 
cell-cycle related changes (Figure 5), as previously reported (Rosner et al., 2013). We found that 
thymidine-induced G1/S-synchronization could increase the percent yield of reprogrammed αMHC-
GFP+ iCMs, while lovastatin-induced G1 synchronization had no significant influence (Figure 4B 
and 4C). However, the absolute number (i.e. yield) of αMHC-GFP+ iCMs was not significantly 
improved by thymidine-synchronization (Figure 4C) but was dramatically decreased by G2/M-
synchronization of nocodazole. 
 
We next investigated the effect of S-phase synchronization, mediated by aphidicolin, hydroxyurea, or 
L-mimosine (Figure 6) as previously reported (Ma et al., 2011), on iCM-reprogramming and found 
that all three compounds significantly suppressed iCM-reprogramming with decreased percentage and 
absolute number of αMHC-GFP+ iCMs (Figure 4D). Interestingly, iCM-reprogramming was inhibited 
by S-phase synchronization only at DPI-1 but not at DPI-2 to DPI-6 (Figure 7), indicating that DPI-1 
is a critical time window for regulating iCM-reprogramming. Importantly, none of the 
synchronizations at DPI-1 inhibited the protein expressions of GMT in infected MEFs (Figure 7D). 
While un-reprogrammed MEFs could quickly recover from cell-cycle arrest and reenter cell cycle 24 
hours after removing compounds (Figure 8), we found that S- or G2/M-synchronization, but not G1-
synchronization, at DPI-1 significantly decreased the percentage of dividing EdU+/αMHC-GFP+ 
GMT-iCMs at DPI-7 (Figure 4E). Our data suggested that S- or G2/M- synchronization at DPI-1 
promoted cell-cycle exit in GMT-reprogrammed iCMs. 
 
2.4.4. S-phase synchronization accelerates the early progression of iCM-reprogramming 
through enhanced cell-cycle exit 
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Our time-lapse recordings showed that iCMs initially expressed a low amount of αMHC-GFP 
(GFPlow) and gradually turned into brighter GFP+ cells (GFPhigh) along with the progress of 
reprogramming (Figure 2A), which was disclosed with varying intensities of GFP fluorescence 
across iCMs by FACS assay (Figure 9A), suggesting that the intensity of GFP fluorescence might 
indicate different progress of reprogramming achieved in individual iCMs. We then gated all 
reprogrammed-αMHC-GFP+ cells at DPI-2, which were newly reprogrammed in theory, as a GFPlow 
sub-population (Figure 9A) and gated remaining αMHC-GFP+ cells with more intense GFP-
fluorescence as a GFPhigh sub-population. We found that GFPhigh iCMs covered a significantly bigger 
portion of αMHC-GFP+ iCMs that exited cell cycle than the GFPlow population, indicated by smaller 
portion of EdU+ iCMs (Figure 9B). We then sorted out GFPlow and GFPhigh populations and found 
that, compared to GFPlow cells, GFPhigh iCMs expressed many cardiac genes at a significantly higher 
level, including Atp2a2, Myl7, Actc1, and Ryr2 (Figure 9C and Figure 10). Consistent with our EdU 
assay, the expression of Mki67, a proliferation marker gene, was significantly lower in GFPhigh cells 
(Figure 9C). These results demonstrated that a more advanced reprogramming had been achieved in 
GFPhigh iCMs. Importantly, S-phase synchronization at DPI-1 significantly increased the portion of 
GFPhigh iCMs at DPI-7 (n=6, Figure 9D), suggesting that S-phase synchronization at DPI-1 
accelerates the early progression of GMT-reprogramming. 
 
It has been reported that a polycistronic construct (MGT), expressing an optimal stoichiometry of 
three reprogramming factors, could yield a better efficiency and a better quality of iCM-
reprogramming in mouse cardiac fibroblasts than GMT monocistronic constructs (Wang et al., 2015). 
We found that GMT- and MGT-reprogramming of MEFs yielded a similar number of iCMs at DPI-3 
through DPI-10 (Figure 9E). Our 48-hour time-lapse recordings also captured cell division and cell 
death in MGT-reprogrammed iCMs (MGT-iCMs) from DPI-2 to DPI-4 (Figure 11); however, the 
number of dividing cells was significantly less in MGT-iCMs than in GMT-iCMs (Figure 9F). 
Consistently, there were significantly less EdU+ cells in MGT-iCMs than in GMT-iCMs within the 
first two weeks of reprogramming (Figure 9G); moreover, MGT-reprogramming was processed 
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faster and yielded significantly higher portion of GFPhigh iCMs than GMT-reprogramming at DPI-7 
and DPI-10 (Figure 9H). These results demonstrated that an advanced progression with enhanced 
cell-cycle exit was achieved in iCMs reprogrammed by polycistronic MGT. Importantly, S-phase 
synchronization failed to further increase the percentage of GFPhigh population among MGT-iCMs 
(Figure 9I), suggesting that the facilitated progression of GMT-reprogramming by S-phase 
synchronization was mediated through a mechanism of accelerating cell-cycle exit (Figure 12). 
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Figure 1. Reprogramming factors were highly expressed in MEFs 48 hours post retrovirus 
infection. A representative western blot image shows the expression of Gata4, Mef2c, and Tbx5 in 
MEFs at different post-infection hours.   
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Figure 2. iCMs undergo cell division and exit cell cycle along the process of reprogramming. A) 
Representative images of a time-lapse recording showing that one primary GMT-iCM (arrowhead) 
divided into two daughter iCMs 20.75 hours after the activation of αMHC-GFP. A scale bar 
indicates 50µm. B) A table summarizing the time-lapse result of GMT-iCMs. Bar graph shows the 
percentage of dividing GMT-iCMs and iCMs that underwent cell death. C) Representative FACS 
plots of αMHC-GFP+ iCMs at day 4 post-infection (DPI-4). D) The percentage of αMHC-GFP+ 
GMT-iCMs from DPI-4 to DPI-21 (n=3). E) Representative FACS plots of 24-hour-incubation 
EdU assay assessing cell division of MEFs and αMHC-GFP+ iCMs. F) Percentage of dividing 
EdU+/αMHC-GFP+ GMT-iCMs from DPI-4 to DPI-21 (n=5). 
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Figure 3. Cardiac reprogramming can be initiated at all three cell-cycle phases. A) Non-
reprogrammed MEFs, which had two consecutive cell divisions in the time-lapse recordings, had 
an average of 25.3±7.4 hours cell-cycle length. B) Representative FACS plot of EdU assay with 
two-hour EdU-labeling showing a distribution of cell-cycle phases in MEFs. C) The average 
percentages of G1-, S-, and G2/M-phase in MEFs (n=4). D) MEFs had an average of 15.2-hour G1 
phase, 7.3-hour S phase, and 2.8-hour G2/M phase. E) The time from the reprogramming-
initiation to cell division in dividing GMT-iCMs (n=34). F) A distribution chart of cell-cycle 
phases in which reprogramming of those dividing iCMs (panel E) was initiated. 
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Figure 4. S- or G2/M-phase synchronization facilitates cell-cycle exit in GMT-reprogrammed iCMs. 
A) At DPI-1, MEFs were synchronized at G1, G0/G1, G1/S, or G2/M-phase by lovastatin, 
serum-free media, thymidine, or nocodazole, respectively. Representative pictures showing 
GMT-reprogrammed MEFs at DPI-10 with or without (Control) cell-cycle synchronization. 
Scale bars indicate 100µm. B) Representative FACS plots of reprogrammed αMHC-GFP+ 
iCMs at DPI-10. C) The effect of G1-, G1/S-, or G2/M-phase synchronization on GMT-
iCMs (n=10), including the percentage (upper panel) and absolute number (lower panel) of 
αMHC-GFP+ iCMs. D) The effect of S-phase synchronization by aphidicolin, hydroxyurea, 
or L-mimosine on GMT-iCMs (n=5). E) The percentage of EdU+ cells in αMHC-GFP+ 
iCMs at DPI-7 with or without cell-cycle synchronization at DPI-1 (n=3). *p<0.05, 
**p<0.01 vs. GMT group.  
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Figure 5. Cell-cycle synchronization of MEFs. A) Experimental schema of cell-cycle synchronization 
and EdU assay. B) Representative pictures (left) and FACS plots (Right) of MEFs without 
(Control) or with a 24-hour incubation of lovastatin (G1), serum-free media (G0/G1), 
thymidine (G1/S), and nocodazole (G2/M). Scale bars indicate 100µm.  
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Figure 6. S-phase synchronization of MEFs. Representative pictures (left) and FACS plots (Right) of 
MEFs without (control) or with a 24-hour incubation of aphidicolin, hydroxyurea, or L-
mimosine synchronization. Scale bars indicate 100µm.   
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Figure 7 DPI-1 is a critical time window for regulating iCM-reprogramming. A) Schema of 
experimental design. B-C) The effect of S-phase synchronization by aphidicolin (B) or 
hydroxyurea (C) from DPI-1 to DPI-6 on the percentage and absolute number of GMT-iCMs. 
*p<0.05; **p<0.01 vs. control. D) Protein expressions of Gata4, Mef2c, and Tbx5 in MEFs 
were not inhibited by any treatments of cell-cycle synchronization.  
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Figure 8. Synchronized MEFs can reenter cell cycle within 24 hrs. FACS plots show that un-
reprogrammed MEFs were synchronized into different cell-cycle phases by relevant 
treatments (left) and reentered cell cycle 24 hours after releasing from synchronization 
(Right).  
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Figure 9. S-phase synchronization or a polycistronic construct (MGT) accelerates the early 
progression of reprogramming and increases the yield of GFPhigh iCMs. A) 
Reprogrammed iCMs were classified into GFPlow and GFPhigh populations. B) Significantly 
less GFPhigh iCMs were stained positive for EdU than GFPlow cells at DPI-7 (n=3) and DPI-10 
(n=6). C) Comparisons of gene expression in GFPlow and GFPhigh iCMs (n=6). D) S-phase 
synchronization at DPI-1 significantly increased GFPhigh cells of GMT-iCMs (n=11). E) A 
similar number of αMHC-GFP+ iCMs (n=3) were reprogrammed by polycistronic MGT or 
monocistronic GMT. F) Time-lapse recordings revealed significantly less dividing cells 
among MGT-iCMs than that among GMT-iCMs. G) EdU assays showed that MGT-iCMs 
exited cell cycle earlier than GMT-iCMs (n=3). H) MGT-reprogramming yielded more 
GFPhigh iCMs than GMT-reprogramming at DPI-7 (n=7) and DPI-10 (n=3). I) S-phase 
synchronization at DPI-1 had no significant improvement on MGT-reprogramming (n=4). 
*p<0.05, **p<0.01 vs. control. 
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Figure 10. Cardiac genes were expressed higher in GFPhigh iCMs than that in GFPlow cells. A) 
Schema of experimental design. B) qRT-PCR analysis of cardiac genes in GFPlow and GFPhigh 
iCMs (n=4).  *p<0.05 vs. GFPlow.  
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Figure 11. MGT-iCMs go through cell division at the early stage of reprogramming. A) 
Representative images of time-lapse recording showing that one MGT-iCM (arrowhead) 
divided into two daughter iCMs. Scale bar indicates 50µm. B) A table summarizing the 
time-lapse result of MGT-reprogrammed αMHC-GFP+ iCMs. Bar graph shows the 
percentage of dividing MGT-reprogrammed iCMs and cells that underwent cell death.  
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Figure 12. Proposed mechanism of reprogramming acceleration with enhanced cell-cycle exit
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Table 1. qRT-PCR primers for gene expression analysis of iCMs 
 
 
  Gene Primer sets Product size (bp) 
Atp2a2 F 5'- TCTACGTGGAACCTTTGCCG -3' 162 
R 5'- GCTGCACACACTCTTTACCG -3' 
Myl7 F 5'- GGTCCCATCAACTTCACCGT -3' 86 
R 5'- AAGGCACTCAGGATGGCTTC -3' 
Actc1 F 5'- TGCCATGTATGTCGCCATCC -3' 86 
R 5'- CACCATCGCCAGAATCCAGA -3' 
Ryr2 F 5'- ACGGCGACCATCCACAAAG -3' 67 
R 5'- AAAGTCTGTTGCCAAATCCTTCT -3' 
Myh6 F 5'- GCCCAGTACCTCCGAAAGTC -3' 110 
R 5'- GCCTTAACATACTCCTCCTTGTC -3' 
GFP F 5'- GGACGACGGCAACTACAAGA  -3' 87 
R 5'- AAGTCGATGCCCTTCAGCTC -3' 
Ttn F 5'- CCGATGTTTACGCAGCCGTTA -3' 62 
R 5'- TCAAAGGTTGCGGTACTACCC -3' 
Slc8a1 F 5'- CTTCCCTGTTTGTGCTCCTGT -3' 78 
R 5'- AGAAGCCCTTTATGTGGCAGTA -3' 
Casq2 F 5'- GCCCAACGTCATCCCTAACA -3' 133 
R 5'- CCCATTCAAGTCGTCTTCCCA -3' 
Apobec2 F 5'- GATCTTCCGCCCTTCGAGATT -3' 130 
R 5'- TCTGTACTTCGACCACATAGCA -3' 
c-Myb F 5'- AGACCCCGACACAGCATCTA -3' 81 
R 5'- CAGCAGCCCATCGTAGTCAT -3' 
Tnnc-1 F 5'- GGAGCTGTCGGATCTCTTCC -3' 155 
R 5'- GGCCATCGTTGTTCTTGTCAC -3' 
Tnni-1 F 5'- ACCATGCCGGAAGTTGAGAG -3' 151 
R 5'- GAATGCGCTCCGAGAGGTAA -3' 
Tnnt-2 F 5'- ACAGAGGAGGCCAACGTAGA -3' 113 
R 5'- AAGTTGGGCATGAAGAGCCT -3' 
Hcn4 F 5'- ACTCCTGGGGGAAGCAGTAT -3' 158 
R 5'- GCCGATGAACATGGCATAGC -3' 
Kcnj5 F 5'- ATACTCCTTCTGGTGCAGGC -3' 95 
R 5'- GCTCTCTTCTTTGGCTGGCT -3' 
Myh7 F 5'- ACTGTCAACACTAAGAGGGTCA -3' 114 
R 5'- TTGGATGATTTGATCTTCCAGGG -3' 
Nppa F 5'- CCCTCGGAGCCTACGAAGAT -3' 80 
R 5'- TGTTGCAGCCTAGTCCACTC -3' 
Nppb F 5'- GATCCGTCAGTCGTTTGGGC -3' 98 
R 5'- AAAGAGACCCAGGCAGAGTCA -3' 
MKi67 F 5'- ATCATTGACCGCTCCTTTAGGT -3' 104 
R 5'- GCTCGCCTTGATGGTTCCT -3' 
aSMA F 5'- ATCACCAACTGGGACGACAT -3' 175 
R 5'- CATACATGGCTGGGACATTG -3' 
Gapdh F 5'- AGGTCGGTGTGAACGGATTTG -3' 123 
R 5'- TGTAGACCATGTAGTTGAGGTCA -3' 
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2.5. DISCUSSION 
 
In this study, we focused on understanding the early progression of iCM-reprogramming and found that 
iCMs did go through cell division at the early stage of reprogramming and ultimately exited cell cycle 
during the process of reprogramming. Importantly, we found that S-phase synchronization at the critical 
initiation time of reprogramming (DPI-1) facilitated the early progression of GMT-reprogramming and 
yielded more GFPhigh iCMs through a mechanism of enhancing cell-cycle exit.  
 
Cell cycle includes two critical phases––a synthesis phase (S-phase) of accurate DNA duplication and a 
mitosis phase of chromosome segregation—which are preceded by two gap phases, G1- and G2-phase 
respectively. Although epigenetic status at S and G2/M phases suppresses global RNA transcription and 
protein synthesis, with the exception of histone proteins (Bou Kheir et al., 2010), our time-lapse 
recordings revealed that the activation of αMHC-GFP was majorly initiated at late G1 and S-phases and 
iCM-reprogramming is processed and continued through more than one cell-cycle. Many reprogrammed 
iCMs did go through cell division soon after αMHC-GFP activation. Very recently, single-cell 
transcriptomics of reprogrammed iCMs reconstructs a path of cell-fate conversion from fibroblast to 
iCMs and disclosed a population of early-stage reprogrammed iCMs that underwent cell division (Liu et 
al., 2017). Furthermore, consistently with previous studies (Addis et al., 2013; Yamakawa et al., 2015; 
Zhou et al., 2017b), we also found that reprogrammed iCMs exited cell cycle at a later stage of 
reprogramming, and S-phase synchronization at DPI-1 facilitated cell-cycle exit in GMT-iCMs and 
yielded fewer reprogrammed iCMs. 
 
Interestingly, the facilitated cell-cycle exit by S-phase synchronization at DPI-1 was accompanied with an 
improved progression of GMT-reprogramming and yielded significantly more GFPhigh iCMs, which 
achieved a more advanced reprogramming than GFPlow cells. This might be due to that cell-cycle exit 
prevents a dilution of GMT expression in individual iCMs and subsequently induce high cardiac gene 
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expression and better reprogramming. It is also true in iCM-reprogramming of polycistronic MGT (Wang 
et al., 2015), which accelerated cell-cycle exit and yielded more GFPhigh iCMs. Because of this 
accelerated progression of MGT-reprogramming, S-phase synchronization failed to further increase the 
GFPhigh portion in MGT-iCMs. It has been shown that active cell-cycle status and maturity have negative 
correlation in iCMs (Zhou et al., 2017b). On the other hand, it has been observed that iCM-
reprogramming was significantly suppressed in an immortalized cardiac fibroblast line that will never exit 
cell cycle (Liu et al., 2017), indicating the importance of cell-cycle exit in iCM-reprogramming. 
Noticeably, our time-lapse recordings also found that some iCMs reprogrammed by either GMT or MGT 
underwent cell death, possibly apoptosis, which could explain why inhibitors of ROCK signaling 
increased the yield of reprogrammed iCMs (Zhao et al., 2015).  
 
In summary, our study provides direct evidence that iCMs actually go through cell division at an early 
reprogramming stage and exit cell cycle along the process of reprogramming. Importantly, our studies 
suggest that cell-cycle exit is one critical event or an indicator of the transition into a more advanced 
reprogramming. Enhanced cell-cycle exit by S-phase synchronization promotes the early progression of 
iCM-reprogramming. Our study provides a mechanistic understanding of iCM-reprogramming, which 
will help us to translate this nascent reprogramming technique into a therapeutic paradigm in the future. 
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2.6. FUTURE DIRECTIONS 
 
In this study, we showed that S-phase synchronization have particular effect on maturation of iCMs 
during reprogramming process through enhancing cell cycle exit. There are some major points to be 
addressed in the future studies. 
 
First, we showed that iCM induction was achieved majorly at late-G1 and S phases, possibly through 
increased accession of reprogramming factors to cardiac gene promoters. Extended S-phase by cell cycle 
synchronization might impose a special epigenetic status, which in turn might allow increased 
transcription of cardiac genes. These suggest that iCM induction might require at least one G1/S 
transition during initiation of reprogramming. Therefore, it needs to be validated through more vigorous 
experiments whether iCM reprogramming essentially requires S-phase epigenetics. 
 
Second point, which needs to be clarified, is the mechanism imposed by S-phase on cell cycle exit. It is 
still unknown why S-phase particularly inducing cell cycle exit in iCMs during reprogramming process 
while not in the plain fibroblasts (Figure 8). However, the findings by Barr et al (2017) supports that S 
or G2/M phase arrest in iCMs by the drugs might induce cell cycle exit in the subsequent cell cycle 
phases possibly through DNA damage response mechanisms. Regardless of this conclusion, mechanism 
of action for facilitated cell cycle exit in iCMs needs to be more extensively examined in future studies.  
 
Another important point is how important the cell-cycle exit is for iCMs. S-phase and use of MGT 
polycistronic construct improved maturity of iCMs and enhanced cell-cycle exit, meaning that cell-cycle 
exit and iCM maturity have positive correlation. The more the chance of cell cycle exit, the better the 
maturity of iCMs. Cell cycle exit in native cardiomyocytes has been an interesting topic so far, however, 
mechanism of cell cycle exit has not been much understood. Therefore, iCMs generated by S-phase could 
be used as a model to understand what really derives cell cycle exit in cardiomyocytes or why it helps 
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maturity of cardiomyocytes. There is a possibility that cardiomyocytes or iCMs exit cell cycle to prevent 
DNA damage so that they can preserve their genomic stability. It might be also possible that telomere 
length is different in reprogrammed iCMs or cardiomyocytes; therefore, they might be more prone to 
DNA damages during active cell cycle progression. However, all these are speculations and need to be 
addressed in future studies. 
 
Last but not least, GFPhigh iCMs were used as a measure of reprogramming quality in our study, however, 
functional aspects of GFPhigh cells, e.g. beating or calcium flux, have not been studied. Therefore, it needs 
to be further validated whether those cells are functionally more mature as well as their maturity in 
expression of cardiac genes. On the other hand, varying intensities of GFP might be a good indicator for 
reprogramming degree of iCMs and could be used for evaluation of reprogramming quality. Therefore, 
single cell quantitative RT-PCR analysis of cells with varying GFP intensities might verify their degree of 
reprogramming and should be addressed in the future studies. Evaluation by GFPhigh iCM population 
might allow us to speed up our quality assessment when comparing two or more experimental groups. 
This could be a helpful way to use in screening novel drugs, RNAs, or compounds which improve quality 
and maturity but not the number or percentage of iCMs. Also, this strategy might be applicable in 
reprogramming of other cell types, which uses fluorescent reporters as similar to αMHC-GFP. 
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